Ten deleterious missense or stop-gain somatic mutations (including the heterozygous PDGFRA D842V mutation) were found in both tumors, along with 3 mutations found only in GIST 2 (Fig. 2a, Table 1). This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.